Fig. 3
The therapeutic process during anti-fungal therapy in the 3rd admission. VRCZ; voriconazole; AMPH: amphotericin B; MCFG: micafungin; GM; galactomannan; BT: body temperature; βDG: β-D glucan [< 20 mg/dL]; WBC: white blood cells [3.0–8.0 × 103/mm3]; CRP: C reactive protein [0.00–0.03 mg/dL]